ImmunityBio
IBRX
#2599
Rank
โ‚ฌ5.83 B
Marketcap
5,49ย โ‚ฌ
Share price
-8.37%
Change (1 day)
195.89%
Change (1 year)

Earnings for ImmunityBio (IBRX)

Earnings in 2026 (TTM): -โ‚ฌ0.77 Billion

According to ImmunityBio's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2025 the company made an earning of -โ‚ฌ0.22 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunityBio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.77 Billion248.87%
2025 -โ‚ฌ0.22 Billion-16.85%
2024 -โ‚ฌ0.27 Billion-36.76%
2023 -โ‚ฌ0.42 Billion28.52%
2022 -โ‚ฌ0.33 Billion5.61%
2021 -โ‚ฌ0.31 Billion54.4%
2020 -โ‚ฌ0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion-82.22%๐Ÿ‡บ๐Ÿ‡ธ USA